Search by Drug Name or NDC

    NDC 00173-0527-00 LAMICTAL 25 mg/1 Details

    LAMICTAL 25 mg/1

    LAMICTAL is a ORAL TABLET, FOR SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by GlaxoSmithKline LLC. The primary component is LAMOTRIGINE.

    Product Information

    NDC 00173-0527
    Product ID 0173-0527_d15a5607-7757-4f62-9269-154d706b67e9
    Associated GPIs 72600040000520
    GCN Sequence Number 021934
    GCN Sequence Number Description lamotrigine TB CHW DSP 25 MG ORAL
    HIC3 H4B
    HIC3 Description ANTICONVULSANTS
    GCN 64322
    HICL Sequence Number 007378
    HICL Sequence Number Description LAMOTRIGINE
    Brand/Generic Brand
    Proprietary Name LAMICTAL
    Proprietary Name Suffix n/a
    Non-Proprietary Name lamotrigine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FOR SUSPENSION
    Route ORAL
    Active Ingredient Strength 25
    Active Ingredient Units mg/1
    Substance Name LAMOTRIGINE
    Labeler Name GlaxoSmithKline LLC
    Pharmaceutical Class Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA020764
    Listing Certified Through 2024-12-31

    Package

    NDC 00173-0527-00 (00173052700)

    NDC Package Code 0173-0527-00
    Billing NDC 00173052700
    Package 100 TABLET, FOR SUSPENSION in 1 BOTTLE (0173-0527-00)
    Marketing Start Date 1998-09-03
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 10.8953
    Pricing Unit EA
    Effective Date 2024-01-01
    NDC Description LAMICTAL 25 MG DISPER TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4
    Classification for Rate Setting B
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis